{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:21:33Z","timestamp":1789546893031,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":14,"publisher":"Springer New York","isbn-type":[{"value":"9781493924493","type":"print"},{"value":"9781493924509","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-2450-9_19","type":"book-chapter","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T11:54:24Z","timestamp":1426506864000},"page":"317-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Isolation and Characterization of Compound-Resistant Isolates of Mycobacterium tuberculosis"],"prefix":"10.1007","author":[{"given":"Theresa","family":"O\u2019Malley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Melief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,14]]},"reference":[{"issue":"11","key":"19_CR1","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1021\/jm500432n","volume":"57","author":"PS Hameed","year":"2014","unstructured":"Hameed PS, Patil V, Solapure S, Sharma U, Madhavapeddi P, Raichurkar A, Chinnapattu M, Manjrekar P, Shanbhag G, Puttur J, Shinde V, Menasinakai S, Rudrapatana S, Achar V, Awasthy D, Nandishaiah R, Humnabadkar V, Ghosh A, Narayan C, Ramya VK, Kaur P, Sharma S, Werngren J, Hoffner S, Panduga V, Kumar CN, Reddy J, Kumar KNM, Ganguly S, Bharath S, Bheemarao U, Mukherjee K, Arora U, Gaonkar S, Coulson M, Waterson D, Sambandamurthy VK, de Sousa SM (2014) Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. J Med Chem 57(11):4889\u20134905. doi:10.1021\/jm500432n","journal-title":"J Med Chem"},{"issue":"2","key":"19_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.tube.2013.12.004","volume":"94","author":"J Simithy","year":"2014","unstructured":"Simithy J, Reeve N, Hobrath JV, Reynolds RC, Calderon AI (2014) Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS. Tuberculosis 94(2):152\u2013158. doi:10.1016\/j.tube.2013.12.004","journal-title":"Tuberculosis"},{"issue":"17","key":"19_CR3","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1128\/JB.00338-06","volume":"188","author":"AJ Harrison","year":"2006","unstructured":"Harrison AJ, Yu M, Gardenborg T, Middleditch M, Ramsay RJ, Baker EN, Lott JS (2006) The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase. J Bacteriol 188(17):6081\u20136091. doi:10.1128\/JB.00338-06","journal-title":"J Bacteriol"},{"issue":"4","key":"19_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1021\/bi0608515","volume":"46","author":"S Kolappan","year":"2007","unstructured":"Kolappan S, Zwahlen J, Zhou R, Truglio JJ, Tonge PJ, Kisker C (2007) Lysine 190 is the catalytic base in MenF, the menaquinone-specific isochorismate synthase from Escherichia coli: implications for an enzyme family. Biochemistry 46(4):946\u2013953. doi:10.1021\/bi0608515","journal-title":"Biochemistry"},{"issue":"8","key":"19_CR5","doi-asserted-by":"publisher","first-page":"e104100","DOI":"10.1371\/journal.pone.0104100","volume":"9","author":"FA de Freitas","year":"2014","unstructured":"de Freitas FA, Bernardo V, Gomgnimbou MK, Sola C, Siqueira HR, Pereira MA, Fandinho FC, Gomes HM, Araujo ME, Suffys PN, Marques EA, Albano RM (2014) Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil. PLoS One 9(8):e104100. doi:10.1371\/journal.pone.0104100","journal-title":"PLoS One"},{"issue":"8","key":"19_CR6","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1128\/AAC.02394-14","volume":"58","author":"A Aono","year":"2014","unstructured":"Aono A, Chikamatsu K, Yamada H, Kato T, Mitarai S (2014) Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58(8):4928\u20134930. doi:10.1128\/AAC.02394-14","journal-title":"Antimicrob Agents Chemother"},{"key":"19_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2014.61","author":"BR Imperiale","year":"2014","unstructured":"Imperiale BR, Di Giulio AB, Adrian Cataldi A, Morcillo NS (2014) Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs. J Antibiot. doi:10.1038\/ja.2014.61","journal-title":"J Antibiot"},{"issue":"6","key":"19_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.tube.2012.07.005","volume":"92","author":"Z Rahim","year":"2012","unstructured":"Rahim Z, Nakajima C, Raqib R, Zaman K, Endtz HP, van der Zanden AG, Suzuki Y (2012) Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh. Tuberculosis 92(6):529\u2013534. doi:10.1016\/j.tube.2012.07.005","journal-title":"Tuberculosis"},{"issue":"10","key":"19_CR9","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1128\/AAC.03277-14","volume":"58","author":"GK Siu","year":"2014","unstructured":"Siu GK, Yam WC, Zhang Y, Kao RY (2014) An upstream truncation of the furA-katG operon confers high-level isoniazid resistance in a Mycobacterium tuberculosis clinical isolate with no known resistance-associated mutations. Antimicrob Agents Chemother 58(10):6093\u20136100. doi:10.1128\/AAC. 03277-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"19_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/mmi.12476","volume":"91","author":"H Ando","year":"2014","unstructured":"Ando H, Miyoshi-Akiyama T, Watanabe S, Kirikae T (2014) A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. Mol Microbiol 91(3):538\u2013547. doi:10.1111\/mmi.12476","journal-title":"Mol Microbiol"},{"issue":"7","key":"19_CR11","doi-asserted-by":"publisher","first-page":"e102135","DOI":"10.1371\/journal.pone.0102135","volume":"9","author":"K Andries","year":"2014","unstructured":"Andries K, Villellas C, Coeck N, Thys K, Gevers T, Vranckx L, Lounis N, de Jong BC, Koul A (2014) Acquired resistance of Mycobacterium tuberculosis to bedaquiline. PLoS One 9(7):e102135. doi:10.1371\/journal.pone.0102135","journal-title":"PLoS One"},{"key":"19_CR12","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2013.0171","author":"Z Sun","year":"2014","unstructured":"Sun Z, Xu Y, Sun Y, Liu Y, Zhang X, Huang H, Li C (2014) Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype. Microb Drug Resist. doi:10.1089\/mdr.2013.0171","journal-title":"Microb Drug Resist"},{"issue":"9","key":"19_CR13","doi-asserted-by":"publisher","first-page":"e75245","DOI":"10.1371\/journal.pone.0075245","volume":"8","author":"TR Ioerger","year":"2013","unstructured":"Ioerger TR, O'Malley T, Liao R, Guinn KM, Hickey MJ, Mohaideen N, Murphy KC, Boshoff HI, Mizrahi V, Rubin EJ, Sassetti CM, Barry CE 3rd, Sherman DR, Parish T, Sacchettini JC (2013) Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One 8(9):e75245. doi:10.1371\/journal.pone.0075245","journal-title":"PLoS One"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-59745-207-6_11","volume":"465","author":"FA Sirgel","year":"2009","unstructured":"Sirgel FA, Wiid IJ, van Helden PD (2009) Measuring minimum inhibitory concentrations in mycobacteria. Methods Mol Biol 465:173\u2013186. doi:10.1007\/978-1-59745-207-6_11","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Mycobacteria Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-2450-9_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T21:42:39Z","timestamp":1676929359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-2450-9_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9781493924493","9781493924509"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-2450-9_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"14 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}